These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30173407)

  • 1. Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease.
    Esteves S; Oliveira S; Duarte-Silva S; Cunha-Garcia D; Teixeira-Castro A; Maciel P
    Mol Neurobiol; 2019 May; 56(5):3626-3637. PubMed ID: 30173407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease.
    Ashraf NS; Duarte-Silva S; Shaw ED; Maciel P; Paulson HL; Teixeira-Castro A; Costa MDC
    Mol Neurobiol; 2019 May; 56(5):3690-3701. PubMed ID: 30187384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.
    Teixeira-Castro A; Jalles A; Esteves S; Kang S; da Silva Santos L; Silva-Fernandes A; Neto MF; Brielmann RM; Bessa C; Duarte-Silva S; Miranda A; Oliveira S; Neves-Carvalho A; Bessa J; Summavielle T; Silverman RB; Oliveira P; Morimoto RI; Maciel P
    Brain; 2015 Nov; 138(Pt 11):3221-37. PubMed ID: 26373603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
    Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
    J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3.
    Duarte-Silva S; Neves-Carvalho A; Soares-Cunha C; Silva JM; Teixeira-Castro A; Vieira R; Silva-Fernandes A; Maciel P
    Mov Disord; 2018 May; 33(5):815-826. PubMed ID: 29570846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
    PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
    Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.
    Nascimento-Ferreira I; Santos-Ferreira T; Sousa-Ferreira L; Auregan G; Onofre I; Alves S; Dufour N; Colomer Gould VF; Koeppen A; Déglon N; Pereira de Almeida L
    Brain; 2011 May; 134(Pt 5):1400-15. PubMed ID: 21478185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models.
    Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L
    Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3.
    Rajamani K; Liu JW; Wu CH; Chiang IT; You DH; Lin SY; Hsieh DK; Lin SZ; Harn HJ; Chiou TW
    Neuropharmacology; 2017 May; 117():434-446. PubMed ID: 28223212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice.
    Mendonça LS; Nóbrega C; Hirai H; Kaspar BK; Pereira de Almeida L
    Brain; 2015 Feb; 138(Pt 2):320-35. PubMed ID: 25527827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
    McLoughlin HS; Moore LR; Chopra R; Komlo R; McKenzie M; Blumenstein KG; Zhao H; Kordasiewicz HB; Shakkottai VG; Paulson HL
    Ann Neurol; 2018 Jul; 84(1):64-77. PubMed ID: 29908063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
    Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
    Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
    Esteves S; Duarte-Silva S; Naia L; Neves-Carvalho A; Teixeira-Castro A; Rego AC; Silva-Fernandes A; Maciel P
    PLoS One; 2015; 10(10):e0141610. PubMed ID: 26505994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
    Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
    Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice.
    Gamage HKAH; Robinson KJ; Luu L; Paulsen IT; Laird AS
    Neurobiol Dis; 2023 Apr; 179():106051. PubMed ID: 36822548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease.
    Simões AT; Gonçalves N; Koeppen A; Déglon N; Kügler S; Duarte CB; Pereira de Almeida L
    Brain; 2012 Aug; 135(Pt 8):2428-39. PubMed ID: 22843411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease.
    Silva-Fernandes A; Duarte-Silva S; Neves-Carvalho A; Amorim M; Soares-Cunha C; Oliveira P; Thirstrup K; Teixeira-Castro A; Maciel P
    Neurotherapeutics; 2014 Apr; 11(2):433-49. PubMed ID: 24477711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.